Non-Motor Symptoms in Parkinson's Disease

Parkinson's disease is often recognised by its characteristic motor impairments, yet non-motor symptoms impose a profound burden on patients from the earliest stages. These manifestations encompass mood disturbances such as depression and apathy, cognitive impairment, sleep and fatigue disorders, autonomic dysfunction affecting gastrointestinal and urinary systems, sensory disturbances including pain and dysesthesia, and sexual dysfunction. Many non-motor features may precede the classical motor signs by years, reflecting widespread α-synuclein pathology beyond the nigrostriatal pathway. These symptoms are highly heterogeneous in onset, severity and progression, and are closely linked to quality of life, caregiver burden and overall prognosis. Standardised instruments such as the Non-Motor Symptoms Scale (NMSS) and self-completed screening questionnaires have been developed to detect and quantify this multidimensional burden. Improved understanding of underlying mechanisms, better longitudinal characterisation and early recognition of specific non-motor profiles are critical for personalised care and for the development of targeted therapies that address the full spectrum of Parkinson’s disease pathology.

Research from Nature Portfolio

A large cross-sectional study of over 1,600 patients across Europe, the Americas and Asia has revealed significant geographical and duration-related differences in non-motor burden. Sleep/fatigue, urinary and sexual symptoms showed distinct regional patterns, while mood and apathy emerged as the strongest predictors of health-related quality of life across all cohorts. A complementary six-year longitudinal investigation in a Taiwanese outpatient cohort demonstrated that total non-motor severity remains relatively stable during the first four to six years of disease but then worsens appreciably. Individual domains followed diverse progression trajectories, and changes in medication dosages appeared unrelated to non-motor severity, underlining the need to address these symptoms independently of dopaminergic regimens.

Non-Motor Symptoms in Parkinson's Disease publication trend

The graph below shows the total number of articles in non-motor symptoms in parkinson's disease across all publications each year (not limited to Nature Index journals).

Technical terms

Non-motor symptoms (NMS): Clinical features of Parkinson’s disease not related to movement, including cognitive, psychiatric, autonomic and sensory disturbances.

Non-Motor Symptoms Scale (NMSS): A clinician-administered instrument designed to quantify the range and severity of non-motor manifestations in Parkinson’s disease.

Unified Parkinson’s Disease Rating Scale (UPDRS): A multi-part scale assessing motor performance, activities of daily living, complications of therapy and non-motor features in Parkinson’s disease.

Motor fluctuations: Variations in motor symptom control that occur as the effects of dopaminergic medication wear off between doses.

References

1. Longitudinal evolution of non-motor symptoms in early Parkinson’s disease: a 3-year prospective cohort study. npj Parkinson's Disease (2021).
2. The Non‐Motor Symptoms Scale in Parkinson’s disease: Validation and use. Acta Neurologica Scandinavica (2020).
3. Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life. Scientific Reports (2021).
4. Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations. Frontiers in Neurology (2021).
5. The severity progression of non-motor symptoms in Parkinson’s disease: a 6-year longitudinal study in Taiwanese patients. Scientific Reports (2021).
6. Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson’s Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up. Journal of Personalized Medicine (2021).